Shanghai Kaibao Pharmaceutical (300039) — Free Cash Flow Generation Index
Shanghai Kaibao Pharmaceutical (300039) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of CN¥187.61 Million represents 1% of operating cash flow (CN¥190.98 Million). Explore capital reinvestment ratio of Shanghai Kaibao Pharmaceutical to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Kaibao Pharmaceutical Free Cash Flow Generation Index (2006–2025)
Historical FCF Generation Index trend for Shanghai Kaibao Pharmaceutical across 20 annual periods. For the full cash flow conversion analysis, see 300039 cash generation efficiency.
Annual Free Cash Flow Generation for Shanghai Kaibao Pharmaceutical (2006–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Kaibao Pharmaceutical. Check Shanghai Kaibao Pharmaceutical investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | CN¥203.70 Million | CN¥230.74 Million | CN¥27.04 Million | ▲ +77.9% |
| 2024 | 0.50x | CN¥138.43 Million | CN¥278.95 Million | CN¥140.52 Million | ▼ -46.3% |
| 2023 | 0.92x | CN¥353.59 Million | CN¥382.66 Million | CN¥29.08 Million | ▲ +0.9% |
| 2022 | 0.92x | CN¥344.80 Million | CN¥376.42 Million | CN¥31.62 Million | ▲ +38.3% |
| 2021 | 0.66x | CN¥83.53 Million | CN¥126.08 Million | CN¥42.55 Million | ▼ -29.8% |
| 2020 | 0.94x | CN¥236.71 Million | CN¥250.65 Million | CN¥13.94 Million | ▼ -1.0% |
| 2019 | 0.95x | CN¥318.63 Million | CN¥334.09 Million | CN¥15.46 Million | ▲ +5.9% |
| 2018 | 0.90x | CN¥236.29 Million | CN¥262.36 Million | CN¥26.07 Million | ▲ +12.6% |
| 2017 | 0.80x | CN¥196.51 Million | CN¥245.76 Million | CN¥49.24 Million | ▼ -12.5% |
| 2016 | 0.91x | CN¥287.85 Million | CN¥314.88 Million | CN¥27.03 Million | ▲ +8.1% |
| 2015 | 0.85x | CN¥276.68 Million | CN¥327.08 Million | CN¥50.40 Million | ▲ +11.8% |
| 2014 | 0.76x | CN¥213.64 Million | CN¥282.38 Million | CN¥68.74 Million | ▲ +34.6% |
| 2013 | 0.56x | CN¥151.95 Million | CN¥270.23 Million | CN¥118.28 Million | ▼ -28.4% |
| 2012 | 0.79x | CN¥191.12 Million | CN¥243.32 Million | CN¥52.21 Million | ▲ +162.1% |
| 2011 | 0.30x | CN¥29.46 Million | CN¥98.31 Million | CN¥68.85 Million | ▲ +119.0% |
| 2010 | -1.58x | CN¥-31.22 Million | CN¥19.79 Million | CN¥51.01 Million | ▼ -14.0% |
| 2009 | -1.38x | CN¥-72.97 Million | CN¥52.74 Million | CN¥125.70 Million | ▼ -449.0% |
| 2008 | 0.40x | CN¥7.41 Million | CN¥18.70 Million | CN¥11.28 Million | ▼ -50.5% |
| 2007 | 0.80x | CN¥18.65 Million | CN¥23.27 Million | CN¥4.62 Million | ▲ +98.3% |
| 2006 | 0.40x | CN¥7.96 Million | CN¥19.70 Million | CN¥11.74 Million | — |